What Burcon makes
Burcon NutraScience is a plant protein technology company listed on the Toronto Stock Exchange and the OTCQB, with press releases datelined Vancouver. Its website presents a portfolio of protein ingredients described as pure, neutral in taste and functional. The core products are isolates, meaning proteins purified to roughly 90% or higher on a dry basis, rather than flours or concentrates.
Three products are described in detail on the site. Peazazz C is a pea protein, FavaPro is a fava protein and Puratein C is a canola protein. Pages for sunflower, hempseed and protein blends also exist in the product menu, so request specifications for those grades. Each named isolate is presented as grown and processed in North America.
For general background on the raw materials, see the pages on pea protein, fava bean protein and rapeseed protein. They explain how isolates differ from concentrates in solubility, flavour and cost, which is the main reason a buyer chooses an isolate for clear beverages or dairy-style products, and what limits each crop.
Peazazz C pea protein
The pea page states a protein purity of over 90% and describes Peazazz C as made from North American non-GMO field peas. The company says it uses a proprietary solvent-free extraction and purification process. It describes the ingredient as dispersible and heat stable, with low sodium, a clean and neutral flavour and aroma, and all essential amino acids.
Listed claims are non-GMO, gluten-free, dairy-free and soy-free. The applications named are dairy alternatives, plant-based cheese, ready-to-mix and ready-to-drink beverages, protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods. No sodium figure, particle size or viscosity data appears, so a developer must request a technical data sheet.
The press section reports the first commercial production run of Peazazz C at the Galesburg, Illinois facility in a release dated 9 June 2025. The chief executive said production came online in under 90 days from commissioning. The release says the plant provides meaningful capacity to scale production, so a buyer should ask for the nameplate tonnage and process detail.
FavaPro fava protein
FavaPro is described as a high-purity isolate with over 90% protein, an off-white colour and a neutral flavour and aroma. The page lists the protein as soluble, with high dispersibility and stability, though no solubility values are given. It describes an excellent amino acid profile without data, and says the extraction uses a proprietary process with no further steps disclosed.
The company points to fava beans being nitrogen-fixing, which it says can reduce the need for synthetic fertiliser. It lists the ingredient as allergen-free and hypoallergenic, gluten-free and non-GMO, and gives its regulatory status as self-affirmed GRAS. A buyer outside the United States should confirm the legal route for fava isolates in the target market before planning a launch.
Applications named for FavaPro are ready-to-drink and ready-to-mix beverages, dairy alternatives, baked goods, snacks and bars, meal replacement products and sports nutrition. Supported claims include high protein, dairy-free, egg-free, vegan and plant-based. Fava isolates can behave differently from pea in gelation and foaming, so trials on the actual matrix remain necessary.
Puratein C canola protein
Puratein C is the canola protein isolate, with a minimum of 90% protein on a dry basis. The page describes high solubility across a broad pH range, heat-set gel formation, foam formation and stability, and emulsifying, thickening and binding properties. Taste is described as mild with sweet notes, odour as neutral, and colour as beige to light yellow.
The company says the amino acid profile is complete and rich in sulphur-containing amino acids, and that the PDCAAS score is high, without stating the value. It gives background that canola seed is about 40% oil and that the double-low variety, introduced in 1974, reduced erucic acid and glucosinolates. The product is listed as gluten-free and non-GMO.
Named uses are meat analogues, dairy alternatives, baked goods, ready-to-drink, ready-to-mix and nutritional beverages, bars and meal replacement products. The page lists no inclusion rates. A developer with an egg or dairy functionality target may find this product worth a bench trial, provided supply volumes and regulatory status in each market are confirmed.
Facilities and company position
Burcon describes a Winnipeg technical centre as its base for over 20 years, with a semi-works production facility and analytical and functionality laboratories. A pilot plant service is offered separately. Commercial production takes place at Galesburg, Illinois, where the company says its proprietary technologies are used to give better taste, colour, functionality and nutrition than conventional proteins.
The news section records financing and guidance changes in September 2026, including an upsized convertible debenture offering and an updated commercial outlook that cites customer demand and investment in manufacturing reliability. The June 2025 release set revenue targets of 1 to 3 million dollars for 2025 and above 10 million dollars for 2026, which are targets rather than results.
A procurement team should treat a listed company still scaling production as a supplier needing diligence. Ask for current output of each isolate, the proportion of capacity under contract, the plan for quality control during ramp-up, and whether the Galesburg plant is operated by the company or a partner. Supply continuity commitments should be written into any agreement.
What a buyer would check
The first request should be a specification and certificate of analysis for each isolate: protein by method with the nitrogen factor stated, moisture, ash, sodium, fat, solubility at defined pH values, particle size, colour values and microbiological limits. The site gives purity as a minimum but publishes no typical analysis, and the basis, dry or as-is, changes the figure.
Second, run functional trials. Compare each isolate against a current reference in the target beverage, bar or dairy-style base for solubility after heat treatment, viscosity, gel strength, foam stability and sensory effect. The trial should also show whether the dose can be lowered enough to offset the price of a high-purity isolate.
Third, review regulatory and sourcing terms. Check the GRAS status or the EU novel food position for each protein, the allergen statement, and documents for non-GMO and country of origin. Ask about lead times, minimum order size, pack formats and the audit rights available, since the production route is proprietary and the commercial plant began operation only in 2025.